Self-emulsifying drug delivery systems: Strategy for improving oral delivery of poorly soluble drugs

Current Drug Therapy

Volumn 2, Issue 1, 2007, Pages 85-93

  Tang, Jing Ling ^a   Sun, Jin ^a   He, Zhong Gui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Bioavailability; Lipid based systems; Oral delivery; Poorly soluble drugs; Self emulsifying; Self microemulsifying

Indexed keywords

ACYLGLYCEROL; ALPHA TOCOTRIENOL; ANTHRACYCLINE; CHINESE DRUG; CURCUMA ZEDOARIA EXTRACT; CYCLOSPORIN A; DANAZOL; DICLOFENAC; DRUG SOLVENT; EPIRUBICIN; EXCIPIENT; LU 28179; MACROGOL; MEFENAMIC ACID; NEW DRUG; NIMESULIDE; OIL; PACLITAXEL; PENCLOMEDINE; PNU 91325; POLYSORBATE 20; POLYSORBATE 80; PROGESTERONE; PUERARIA EXTRACT; PUERARIA LOBATA EXTRACT; SILIBININ; SURFACTANT; UBIDECARENONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCA ALKALOID;

AQUEOUS SOLUTION; CHINESE MEDICINE; CURCUMA LONGA; CYTOTOXICITY; DILUTION; DISSOLUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG SOLUBILITY; EMULSION; LIPOLYSIS; LIPOPHILICITY; LYMPH FLOW; MICROEMULSION; NONHUMAN; PRIORITY JOURNAL; PUERARIA; REVIEW; SELF EMULSIFYING DRUG DELIVERY SYSTEM; SINGLE DRUG DOSE; TABLET FORMULATION;

EID: 34248152851     PISSN: 15748855     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488507779422400     Document Type: Review

References (79)

1. Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm 2001; 212: 233-46.
2. Aungst BJ. Novel formulation strategies for improving oral bioavailabitity of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci 1993; 82: 979-87.
3. Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Del Rev 1997; 25: 103-28.
4. Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Del Rev 1997; 25: 47-58.
5. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004; 58: 173-82.
6. Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm 2000; 50: 179-88.
7. Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994; 106: 15-23.
8. Craig DQM, Lievens HSR, Pitt KG, Storey DE. An investigation into physico-chemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. Int J Pharm 1993; 96: 147-55.
9. Charman SA, Charman WN, Rogge MC, Wilson TD, Dutko FJ, Pouton CW. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res 1992; 9: 87-93.
10. Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res 1995; 12: 1561-72.
11. Porter CJ, Charman WN. In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev 2001; 50 Suppl 1: S127-47.
12. MacGregor KJ, Embleton JK, Perry EA, et al. Lipolysis of oily formulations in the gastro-intestinal tract. Adv Drug Delivery Rev 1997; 25: 3346.
13. O'Driscoll CM. Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 2002; 15: 405-15.
14. Devani M, Ashford M, Craig DQ. The emulsification and solubilisation properties of polyglycolysed oils in self-emulsifying formulations. J Pharm Pharmacol 2004; 56: 307-16.
15. Odeberg JM, Kaufmann P, Kroon KG, Hoglund P. Lipid drug delivery and national formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine. Eur J Pharm Sci 2003; 20: 375-82.
16. Palamakula A, Khan MA. Evaluation of cytotoxicity of oils used in coenzyme Q10 Self-emulsifying Drug Delivery Systems (SEDDS). Int J Pharm 2004; 273: 63-73.
17. Gursoy N, Garrigue JS, Razafindratsita A, Lambert G, Benita S. Excipient effects on in vitro cytotoxicity of a novel paclitaxel self-emulsifying drug delivery system. J Pharm Sci 2003; 92: 2411-8.
18. Charman WN, Porter CJ, Mithani S, Dressman JB. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 1997; 86: 269-82.
19. Porter CJH, Charman WN. Uptake of drugs into the intestinal lymphatics after oral administration. Adv Drug Deliv Rev 1997; 25: 71-89.
20. Porter CJH, Charman WN. Intestinal lymphatic transport: an update. Adv Drug Deliv Rev 2001; 50: 61-80.
21. Muranishi S. Drug targeting towards the lymphatics. Adv Drug Res 1991; 21: 1-38.
22. Benet L. The drug efflux-metabolism alliance: biochemical aspects. Adv Drug Deliv Rev 2001; 50: S3-S11.
23. Dintaman JM, Silverman JA, Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999; 16: 1550-6.
24. Nerurkar MM, Burton PS, Borchardt RT. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Pharm Res 1996; 13: 528-34.
25. Aungst BJ. Intestinal permeation enhancers. J Pharm Sci 2000; 89: 429-42.
26. Muranishi S. Absorption enhancers. Crit Rev Ther Drug Carrier Syst 1990; 7: 1-33.
27. Charman WN, Noguchi T, Stella VJ. An experimental system designed to study the in situ intestinal lymphatic transport of lipophilic drugs in anesthetized rats. Int J Pharm 1986; 33: 155-64.
28. Myers RA, Stella VJ. Factors affecting the lymphatic transport of penclomedine (NSC-338720), a lipophilic cytotoxic drug: Comparison to DDT and hexachlorobenzene. Int J Pharm 1992; 80: 511-62.
29. Khoo SM, Porter CJH, Edwards GA, Charman WN. Intestinal lymphatic transport is the primary route for halofantrine after oral postprandial administration. Pharm Sci 1999;1: S-624.
30. Haus DJ, Fogal SE, Ficorilli JV. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci 1998; 87: 164-9.
31. Makhey VD, Guo A, Norris DA, Hu P, Yan J, Sinko PJ. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm Res 1998; 15: 1160-7.
32. Lo YL, Hsu CY, Huang JD. Comparison of effects of surfactants with other MDR reversing agents on intracellular uptake of epirubicin in Caco-2 cell line. Anticancer Res 1998; 18: 3005-9.
33. Lo YL, Huang JD. Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. Biochem Pharmacol 2000; 59: 665-72.
34. Lo YL. Phospholipids as multidrug resistance modulators of the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. Biochem Pharmacol 2000; 60: 1381-90.
35. Batrakova E, Lee S, Li S, Venne A, Alakhov V, Kabanov A. Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm Res 1999; 16: 1373-9.
36. Batrakova EV, Li S, Miller DW, Kabanov AV. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm Res 1999; 16: 1366-72.
37. Yamazaki T, Sato Y, Hanai M, et al. Non-ionic detergent Tween 80 modulates VP-16 resistance in classical multidrug resistant K562 cells via enhancement of VP-16 influx. Cancer Lett 2000; 149: 153-61.
38. Dudeja PK, Anderson KM, Harris JS, Buckingham L, Coon JS. Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. Arch Biochem Biophys 1995; 319: 309-15.
39. Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999; 16: 1550-6.
40. Friche E, Jensen PB, Sehested M, Demant EJ, Nissen NN. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. Cancer Commun 1990; 2: 297-303.
41. Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev 2002; 54: 759-79.
42. Schuldes H, Dolderer JH, Zimmer G, et al. Reversal of multidrug resistance and increase in plasma membrane fluidity in CHO cells with R-verapamil and bile salts. Eur J Cancer 2001; 37: 660-7.
43. Dolderer JH, Zimmer G, Woodcock BG, Bockhom H, Bickeboller R, Schuldes H. Resistance modulation in CHO cells by R-veraparmil and bile salts is associated with physical and chemical changes in the cell membrane. Int J Clin Pharmacol Ther 2000; 38: 196-203.
44. Lo YL. Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. J Control Release 2003; 90: 37-48.
45. Komarov PG, Shtil AA, Buckingham LE, et al. Inhibition of cytarabine-induced MDR1 (P-glycoprotein) gene activation in human tumor cells by fatty acid-polyethylene glycol-fatty acid diesters, novel inhibitors of P-glycoprotein function. Int J Cancer 1996; 68: 245-50.
46. Embleton JY, Pouton CW. Structure and activity of gastrointestinal lipases. Adv Drug Delivery Rev 1997; 25: 15-32.
47. Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci 2000; 11: S93-8.
48. de Smidt PC, Campanero MA, Troconiz IF. Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility. Int J Pharm 2004; 270: 109-18.
49. Yap SP, Yuen KH. Influence of lipolysis and droplet size on tocotrienol absorption from self-emulsifying formulations. Int J Pharm 2004; 281: 67-78.
50. Corbo DC, Liu JC, Chien YW. Characterization of the barrier properties of mucosal membranes. J Pharm Sci 1990; 79: 202-6.
51. Rojanasakul Y, Wang LY, Bhat M, Glover DD, Malanga CJ, Ma JKH. The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit. Pharm Res 1992; 9: 1029-34.
52. Gershanik T, Benita S. Positively charged self-emulsifying oily formulation for improving oral bioavailability of progesterone. Pharm Develop Technol 1996; 1: 147-57.
53. Gershanik T, Benzeno S, Benita S. Interaction of the self-emulsifying lipid drug delivery system with mucosa of everted rat intestine as a function of surface charge and droplet size. Pharm Res 1998; 15: 863-9.
54. Gershanik T, Haltner E, Lehr CM, Benita S. Charge-dependent interaction of self-emulsifying oil formulations with Caco-2 cells monolayers: binding, effects on barrier function and cytotoxicity. Int J Pharm 2000; 211: 29-36.
55. Poelma FG, Breas R, Tukker JJ, Crommelin DJ. Intestinal absorption of drugs. The influence of mixed micelles on on the disappearance kinetics of drugs from the small intestine of the rat. J Pharm. Pharmacol 1991; 43: 317-24.
56. Gao P, Rush BD, Pfund WP, et al. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailabitity. J Pharm Sci 2003; 92: 2386-98.
57. Gao P, Guyton ME, Huang T, Bauer JM, Stefanski KJ, Lu Q. Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations. Drug Dev Ind Pharm 2004; 30: 221-9.
58. Pellet MA, Davis AF, Hadgraft J. Effect of supersaturation on membrane transport: 2. Piroxicam. Int J Pharm 1994; 111: 1-6.
59. Pellet MA, Roberts MS, Hadgraft J. Supersaturated solutions evaluated with an intro stratum corneum tape stripping technique. Int J Pharm 1997; 151: 91-8.
60. Usui F, Maeda K, Kusai A, Nishimura K, Yamamoto K. Inhibitory effects of water soluble polymers on precipitation of RS-8359. Int J Pharm 1997; 154: 59-66.
61. Yamada T, Saito N, Imai T, Otagiri M. Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug. Chem Pharm Bull 1999; 47: 1311-3.
62. Raghavan SL, Trividic A, Davis AF, Hadgraft J. Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate. Int J Pharm 2000; 193: 231-7.
63. Iervolino M. Raghavan SL, Hadgraft J. Membrane penetration enhancement of ibuprofen using supersaturation. Int J Pharm 2000; 198: 229-38.
64. Raghavan SL, Kiepfer B, Davis AF, Kazarian SG, Hadgraft J. Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers. Int J Pharm 2001 Jun 19; 221(1-2): 95-105.
65. Pellet MA, Castellamo S, Hadgraft J, Davis AF. The penetration of supersaturated solutions of piroxicam across silicone membranes and huamn skin in vitro. J Control Release 1997; 46: 205-14.
66. Hasegawa A, Taguchi M, Suzuki R, Miyata T, Nakagawa H, Sugimoto I. Supersaturation mechanism of drugs from solid dispersions with enteric coating agents. Chem Pharm Bull 1988; 36: 4941-50.
67. Tuleu C, Newton M, Rose J, et al. Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J Pharm Sci 2004; 93: 1495-502.
68. Franceschinis E, Voinovich D, Grassi M, et al. Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption. Int J Pharm 2005; 291: 87-97.
69. Attama AA, Nzekwe IT, Nnamani PO, Adikwu MU, Onugu CO. The use of solid self-emulsifying systems in the delivery of diclofenac. Int J Pharm 2003; 262: 23-8.
70. Hansen T, Holm P, Rohde M, Schultz K. In vivo evaluation of tablets and capsules containing spray-dried o/w-emulsions for oral delivery of poorly soluble drugs. Int J Pharm 2005; 293: 203-11.
71. Woo JS, Suh HJ. Oral micro-emulsion composition of silybin. WO Patent No. 0 101 961.
72. You J, Cui FD, Li QP, Han X, Yu YW, Yang MS. A novel formulation design about water-insoluble ody drug: preparation of zedoary turmeric oil microspheres with self-emulsifying ability and evaluation in rabbits. Int J Pharm 2005; 288: 315-23.
73. Li GD, Xu F, Shen AJ. Self-emulsifying preparation of curcuma oil. Acad J Sec Mil Med Univ 2002; 23: 896-8.
74. Cui SM, Zhao CS, Tang X, Chen DW, He ZG. Biomed Chromatogr 2005; 19: 375-8.
75. Cui SM, Zhao CS, Chen DW, He ZG. Drug Dev Ind Pharm, 2005; 31: 349-56.
76. Kleijnen J, Knipschild P. Lancet 1992; 340: 1136-9.
77. Kressmann S, Biber A, Wonnemann M, Schug B, Blume HH, Muller WE. J Pharm Pharmacol 2002; 54: 1507-14.
78. Kressmarm S, Muller WE, Blume HH. J Pharm Pharmacol 2002; 54: 661-9.
79. Tang JL, Sun J, Sun YH, Cui FD, He ZG. Chromatographia 2006; 63: 53-58.